Design of Allosteric Stimulators of the Hsp90 ATPase as New Anticancer Leads
Ilda D’Annessa(Institute of Chemistry of Molecular Recognition), Giorgio Colombo(University of Pavia), Carlos Sànchez‐Martìn(University of Padua), Sara Sattin(University of Milan), Elisabetta Moroni, Nadia Zaffaroni(Fondazione IRCCS Istituto Nazionale dei Tumori), Jiahui Tao(University of California, San Francisco), David A. Agard(University of California, San Francisco), Anna Bernardi(University of Milan), Andrea Rasola(University of Padua), Marzia Pennati(Fondazione IRCCS Istituto Nazionale dei Tumori)
Cited by 40
Related Papers
Isolation and <i>In vitro</i> Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties
|Cancer Research|2005|1.7k
Human Bone Marrow–Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-term<i>In vitro</i>Culture and Do Not Exhibit Telomere Maintenance Mechanisms
|Cancer Research|2007|702
Multivalent glycoconjugates as anti-pathogenic agents
|Chemical Society Reviews|2012|534
miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase Cε
|Cancer Research|2009|363
Rational design of shepherdin, a novel anticancer agent
|Cancer Cell|2005|348